AcelRx Pharmaceuticals Aktie

0,8910EUR
+0,0340EUR
+3,97%
19:42:00
1,07USD
+0,01USD
+0,94%
20:26:17

WKN: A1H64B / ISIN: US00444T1007 / Symbol: ACRX

  Kaufen  
Verkaufen
oder
Werbung

AcelRx Pharmaceuticals Aktien News

10.09.21AcelRx Pharmaceuticals to Participate in Two September Investor Conferences (PR Newswire)
30.08.21Study Results Announced During Award-Winning Presentation on the Effect of Sufentanil Sublingual Tablet on Outpatient Plastic Surgery at the Annual Miami Cosmetic Surgery Event (PR Newswire)
26.08.21Presentation on the Effect of the Administration of Sufentanil Sublingual Tablet on Reducing Post-Operative Recovery Time and Opioid Use in Plastic Surgery at the Annual Miami Cosmetic Surgery Event (PR Newswire)
16.08.21AcelRx Pharmaceuticals Reports Second Quarter 2021 Financial Results (PR Newswire)
09.08.21SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in AcelRx Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadline - ACRX (PR Newswire)
09.08.21AcelRx to Host Second Quarter 2021 Financial Results Call and Webcast on August 16, 2021 (PR Newswire)
04.08.21SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in AcelRx Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadline - ACRX (PR Newswire)
29.07.21SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in AcelRx Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadline - ACRX (PR Newswire)
28.07.21Deadline Reminder: Law Offices of Howard G. Smith Reminds Investors of Looming Deadline in the Class Action Lawsuit Against AcelRx Pharmaceuticals, Inc. (ACRX) (PR Newswire)
23.07.21Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against AcelRx Pharmaceuticals, Inc. (ACRX) (PR Newswire)
21.07.21The Law Offices of Frank R. Cruz Announces the Filing of a Securities Class Action on Behalf of AcelRx Pharmaceuticals, Inc. (ACRX) Investors (PR Newswire)
18.07.21SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in AcelRx Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadline - ACRX (PR Newswire)
18.07.21SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in AcelRx Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadline - ACRX (PR Newswire)
14.07.21AcelRx Enters into Licensing Agreement for DZUVEO® in Europe and In-licensing Agreement for Two Products in the U.S. (PR Newswire)
10.07.21SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in AcelRx Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadline - ACRX (PR Newswire)
02.07.21SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in AcelRx Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadline - ACRX (PR Newswire)
01.07.21Deadline Reminder: Law Offices of Howard G. Smith Reminds Investors of Looming Deadline in the Class Action Lawsuit Against AcelRx Pharmaceuticals, Inc. (ACRX) (PR Newswire)
23.06.21Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against AcelRx Pharmaceuticals, Inc. (ACRX) (PR Newswire)
16.06.21SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in AcelRx Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadline - ACRX (PR Newswire)
08.06.21Pomerantz Law Firm Announces the Filing of a Class Action Against AcelRx Pharmaceuticals, Inc. and Certain Officers - ACRX (PR Newswire)

AcelRx Pharmaceuticals News

AcelRx Pharmaceuticals News: auf dieser Seite finden Sie alle AcelRx Pharmaceuticals News und Nachrichten zur AcelRx Pharmaceuticals Aktie. Dies beinhaltet die Agentur-Feeds auf finanzen.net, aber auch AcelRx Pharmaceuticals News auf einer Vielzahl externer Seiten. Externe Links sind am entsprechenden Link-Symbol zu erkennen. Um AcelRx Pharmaceuticals News auf externen Seiten zu lesen, folgen Sie einfach dem entsprechenden Link.
Werbung

Meistgelesene AcelRx Pharmaceuticals News

Keine Nachrichten gefunden.
Weitere AcelRx Pharmaceuticals News

AcelRx Pharmaceuticals Peer Group News

Keine Nachrichten gefunden.
finanzen.net zero
finanzen.net zero

Oskar

ETF-Sparplan

Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.
Zur klassischen Ansicht wechseln